|
2022
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors. Compounds of formula (I) are useful as LRRK2 kinase inhibitors. |
|
2021
|
Invention
|
New macrocyclic lrrk2 kinase inhibitors. Compounds of formula (I): wherein R, X1, X2, X3, Z1, Z2,... |
|
|
Invention
|
Macrocyclic rip2-kinase inhibitors. The present invention relates to macrocyclic compounds and co... |
|
2017
|
G/S
|
Recherche scientifique et médicale dans le domaine de la cancérologie; conception et développemen... |
|
|
Invention
|
Radiolabeled macrocyclic egfr inhibitor. The present invention relates to 18-Fluor radiolabeled m... |
|
2016
|
G/S
|
Logiciels permettant d'identifier des cibles thérapeutiques, d'identifier les populations résista... |
|
|
Invention
|
Macrocyclic activin-like receptor kinase inhibitors. The present invention relates to macrocyclic... |
|
2015
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors. The present invention relates to novel macrocyclic compounds... |
|
|
Invention
|
Macrocyclic rip2 kinase inhibitors. The present invention relates to macrocyclic compounds and co... |
|
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors. The present invention relates to novel macrocylic compounds ... |
|
|
Invention
|
Macrocyclic flt3 kinase inhibitors. The present invention relates to macrocylic compounds and com... |
|
|
Invention
|
Macrocyclic tgf-br2 kinase inhibitors. The present invention relates to macrocyclic compounds and... |
|
2014
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors.
The present invention relates to macrocyclic compounds and ... |
|
|
Invention
|
Macrocyclic salt-inducible kinase inhibitors. The present invention relates to macrocyclic compou... |
|
|
Invention
|
Macrocyclic rip2 kinase inhibitors.
The present invention relates to macrocyclic compounds and c... |
|
|
Invention
|
Macrocyclic lrrk2 kinase inhibitors. The present invention relates to macrocyclic compounds and c... |
